David Fajgenbaum on Drug Repurposing, AI, and the Future of Healthcare

From Athlete to ICU Survivor

• athlete David Fajgenbaum went from a healthy college football player to critically ill with a rare, deadly condition called idiopathic multicenter Castleman disease.
• 🏥 He faced near-death experiences multiple times, with doctors preparing his family for his passing, but survived through high-dose chemotherapy.
• 💡 This near-death experience inspired him to find a drug to save his life, realizing that creating a new drug was impossible within his timeframe and financial constraints.

The Power of Drug Repurposing

• 💊 Fajgenbaum discovered that existing FDA-approved drugs, particularly generics, could be repurposed for diseases lacking treatments, as they often target underlying molecular problems.
• 💰 A major hurdle is the lack of financial incentive for pharmaceutical companies to pursue new uses for generic drugs, as there's no patent protection or profit motive.
• 💡 Examples of repurposed drugs include Viagra (initially for heart disease, now for erectile dysfunction and a pediatric lung condition), Thalidomide (from morning sickness to leprosy and multiple myeloma), and Lithium (for bipolar disorder and potentially Alzheimer's).
• 💉 Lidocaine, a common numbing agent, showed a significant reduction in mortality when injected around breast cancer tumors before surgery, yet uptake has been minimal due to lack of commercial incentive.
• 📈 GLP-1 agonists, known for metabolic health, are also showing promise for neuroprotective benefits and improving symptoms in Parkinson's and reducing Alzheimer's risk.

Every Cure and AI's Role

• 🎯 Every Cure, a nonprofit founded by Fajgenbaum, aims to overcome the financial, data, and responsibility hurdles in drug repurposing.
• 🤖 AI is crucial for scanning vast amounts of biological and medical data to identify high-probability drug-disease matches from millions of possibilities, significantly accelerating the discovery process.
• 🚀 The organization has advanced 14 repurposed treatments and is actively pursuing nine more, focusing on conditions with strong matches, significant impact, and feasibility for a nonprofit.
• 🧩 Notable advancements include DFMO for the rare Bachmann-Bup syndrome and continued research into lidocaine for breast cancer.

The Future of Healthcare

• 🔮 Fajgenbaum predicts that AI will automate many tasks currently requiring human brains, transforming industries including healthcare.
• 🩺 While AI can aid in diagnosis and workflow improvement, the role of doctors may evolve as AI takes on more diagnostic functions, potentially leading to a future with fewer doctors in the loop for certain processes.
• 💡 He emphasizes that directing AI towards existing drugs and data, especially for non-profitable opportunities, is key to truly transforming healthcare and potentially eradicating diseases.